Champions Oncology, Inc.

NASDAQ:CSBR

4.25 (USD) • At close September 5, 2024
Bedrijfsnaam Champions Oncology, Inc.
Symbool CSBR
Munteenheid USD
Prijs 4.25
Beurswaarde 57,773,650
Dividendpercentage 0%
52-weken bereik 3.97 - 7.13
Industrie Biotechnology
Sector Healthcare
CEO Dr. Ronnie Morris M.D.
Website https://www.championsoncology.com

An error occurred while fetching data.

Over Champions Oncology, Inc.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology

Vergelijkbare Aandelen

Candel Therapeutics, Inc. logo

Candel Therapeutics, Inc.

CADL

6.14 USD

Alaunos Therapeutics, Inc. logo

Alaunos Therapeutics, Inc.

TCRT

2.42 USD

Immuneering Corporation logo

Immuneering Corporation

IMRX

1.18 USD

Leap Therapeutics, Inc. logo

Leap Therapeutics, Inc.

LPTX

2.81 USD

TELA Bio, Inc. logo

TELA Bio, Inc.

TELA

2.75 USD

KORU Medical Systems, Inc. logo

KORU Medical Systems, Inc.

KRMD

2.46 USD

Anixa Biosciences, Inc. logo

Anixa Biosciences, Inc.

ANIX

3.21 USD

Taysha Gene Therapies, Inc. logo

Taysha Gene Therapies, Inc.

TSHA

2.04 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)